Skip to main content

Table 1 Age distribution (at time of consent)

From: Feasibility of a randomized single-blind crossover trial to assess the effects of the second-generation slow-release dopamine agonists pramipexole and ropinirole on cued recall memory in idiopathic mild or moderate Parkinson’s disease without cognitive impairment

Age (years)

Frequency

51–55

2 (female = 1, male = 1)

56–60

4 (female = 1, male = 3)

61–65

6 (female = 2, male = 4)

66–70

3 (female = 1, male = 2)

71–75

5 (female = 1, male = 4)

76–80

2 (male = 2)

Back to article page

Pilot and Feasibility Studies

ISSN: 2055-5784